Zanubrutinib monotherapy in CD79B-mutated relapsed or refractory diffuse large B-cell lymphoma: A multicenter Phase 2 study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Zanubrutinib Alone for CD79B-Mutated Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Multicenter Phase 2 Trial

  • By

  • Li Wang

  • Keshu Zhou

  • Fei Li

  • Qingyuan Zhang

  • Hui Zhou

  • Ou Bai

  • Liping Su

  • Chunhong Hu

  • Zhi-Ming Li

  • Kaiyang Ding

  • Qunyi Guo

  • Xiaoling Li

  • Xiaoxi Zhou

  • Wenjuan Yu

  • Shuhua Yi

  • Zhixia Wei

  • Wenbin Qian

  • Feiheng Chen

  • Guohui Cui

  • Zhiyu Liang

  • Qingchao Zeng

  • Jiaoyan Lyu

  • Yang Liu

  • Pan Zhang

  • Zhirong Shen

  • Zaixing Shi

  • Jing Rong

  • Wei-Li Zhao

  • October 15, 2026

Share

Original Source(s)

Zanubrutinib monotherapy in CD79B-mutated relapsed or refractory diffuse large B-cell lymphoma: A multicenter Phase 2 study

  • by Li Wang, Keshu Zhou, Fei Li, Qingyuan Zhang, Hui Zhou, Ou Bai, Liping Su, Chunhong Hu, Zhi-Ming Li, Kaiyang Ding, Qunyi Guo, Xiaoling Li, Xiaoxi Zhou, Wenjuan Yu, Shuhua Yi, Zhixia Wei, Wenbin Qian, Feiheng Chen, Guohui Cui, Zhiyu Liang, Qingchao Zeng, Jiaoyan Lyu, Yang Liu, Pan Zhang, Zhirong Shen, Zaixing Shi, Jing Rong, Wei-Li Zhao

  • October 15, 2026

Related Content

Comment on: Optimizing surveillance in Lynch syndrome: lesion detection and comparative performance of different colonoscopy modalities, a systematic review and network meta-analysis

Screening strategies for the early detection of non-cardia gastric cancer in low- to moderate-prevalence regions: Asia-Pacific gastroesophageal cancer congress consensus 2026

Parents’ Perspectives on Using Computerized Cognitive Training to Manage Cognitive Late Effects in Children With Cancer: Qualitative Descriptive Study